Gauthier, J
Holmberg, L
Wu, D
Bensinger, W
Gopal, A K
Press, O
Maloney, D
Green, D J
Till, B G
Byelykh, D
Shustov, A
Article History
First Online: 24 October 2016
Competing interests
: Gopal AK: Merck: Research Funding; Emergent/Abbott: Research Funding; Cephalon/Teva: Research Funding; BioMarin: Research Funding; Sanofi-Aventis: Honoraria; Millenium: Honoraria, Research Funding; Seattle Genetics: Consultancy, Honoraria, Research Funding; Janssen: Consultancy, Research Funding; Pfizer: Consultancy, Research Funding; Spectrum: Consultancy, Research Funding; Gilead: Consultancy, Research Funding; Piramal: Research Funding; Biogen Idec, BMS: Research Funding. Maloney D: Juno Therapeutics: Research Funding; Roche/Genentech: Honoraria; Janssen Scientific Affairs: Honoraria; Seattle Genetics: Honoraria. Till: Roche-Genentech: Research Funding. Shustov A: Celgene: Honoraria and consultancy, Spectrum and BMS: consultancy.